MapLight Therapeutics, Inc. (MPLT) Institutional Ownership & Insider Trading
106 institutions reported holding MapLight Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 156 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MPLTMapLight Therapeutics, Inc.Follow MPLT — free
—
Price chart with a free account
- Market cap
- 369.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 1 Dec, in 37 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters106 institutions held 56.6% of the shares. Across filers that reported both quarters, shares held changed +6.1%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 106 | 26 | +6.1% | 20 | 35 | 28 | 8 |
| Mar 26 | 80 | 25 | -4.7% | 26 | 17 | 12 | 14 |
| Dec 25 | 74 | 26 | — | — | — | — | — |
MapLight Therapeutics, Inc. — questions
- Who owns MapLight Therapeutics, Inc. stock?
- 106 institutions reported MapLight Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: NOVO HOLDINGS A/S (8.0%), FCPM III SERVICES B.V. (7.0%), T. Rowe Price Investment Management, Inc. (6.0%).
- Are MapLight Therapeutics, Inc. insiders buying or selling?
- 156 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from MapLight Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.